Science and the SPARK Norway partners organize monthly open meetings.
On November 6th, Bjørn Pedersen, Managing Director of Diatec Monoclonals, was together with Catapult Life Science, invited to speak on the topic “Early phase production”.
points were: Procedures that work in the lab don’t always scale-up seamlessly
into production in the life science industry. Process development while staying
compliant will be required. What should be considered when you work in
lab-scale to make the transition to production smoother? What are the common
pitfalls, and what are the dos and don’ts?
emphasized the importance of Quality Management.
About Diatec Diatec Monoclonals is a premiere European provider of monoclonal antibodies (mAbs) for biopharmaceuticals, human and veterinary diagnostics, and food analysis.
About SPARK Norway SPARK Norway – a two-year innovation program
Science’s innovation program for health-related topics in the life science
domain. Mentoring, milestone-based funding and education to further develop
your ideas. Uptake through annual open calls.
Norway is led by UiO:Life Science and supported by UiO’s top management, Inven2
and OUS. Representatives from the clusters Oslo Cancer Cluster, The Life
Science Cluster, Nansen Neuroscience Network, Norwegian Inflammation Network
and Norway Health Tech as well as the Association of Pharmaceutical Industry in
Norway (LMI), ShareLab and The Norwegian Medicines Agency are members of the
SPARK Norway management team.